Universal Ibogaine Inc (IBO.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 07/31
| 10-2022 | 07-2022 | 04-2022 | 01-2022 | 10-2021 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 66 | 79 | 72 | 69 | 47 |
| Accounts receivable | 114 | N/A | N/A | N/A | N/A |
| Other Working Capital | 228 | -702 | 297 | -98 | -4 |
| Other Operating Activity | -859 | -1,089 | -1,134 | -1,087 | -782 |
| Operating Cash Flow | $-450 | $-1,712 | $-765 | $-1,116 | $-740 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -143 | -12 | -84 | 12 | N/A |
| Net Acquisitions | 0 | 618 | 0 | 0 | -2,666 |
| Other Investing Activity | 0 | 0 | 0 | 0 | 43 |
| Investing Cash Flow | $-143 | $606 | $-84 | $12 | $-2,623 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | -22 | N/A | N/A | N/A | N/A |
| Debt Issued | 583 | 0 | 0 | 0 | 1,630 |
| Debt Repayment | N/A | -122 | -272 | -29 | N/A |
| Common Stock Issued | 10 | 0 | 0 | 0 | 6,074 |
| Other Financing Activity | 0 | 0 | 0 | 18 | -293 |
| Financing Cash Flow | $571 | $-122 | $-272 | $-11 | $7,411 |
| Beginning Cash Position | 726 | 1,954 | 3,075 | 4,190 | 142 |
| End Cash Position | 704 | 726 | 1,954 | 3,075 | 4,190 |
| Net Cash Flow | $-22 | $-1,228 | $-1,121 | $-1,115 | $4,048 |
| Free Cash Flow | |||||
| Operating Cash Flow | -450 | -1,712 | -765 | -1,116 | -740 |
| Capital Expenditure | -143 | -12 | -84 | N/A | N/A |
| Free Cash Flow | -594 | -1,724 | -849 | -1,116 | -740 |